Home » Topics » BioWorld Science

BioWorld Science
RSS

Lactobacillus reuteri may reduce bone loss in older women

May 2, 2018

Genocea files IND for phase I/IIa study of GEN-009

May 2, 2018

DKFZ patents novel KLK6 inhibitors

May 2, 2018

FDA approves Kymriah for relapsed or refractory large B-cell lymphoma

May 2, 2018

Spark Therapeutics sells priority review voucher to Jazz Pharmaceuticals

May 2, 2018

AbbVie submits European MAA for risankizumab in moderate to severe plaque psoriasis

May 2, 2018

FDA grants QIDP and fast track designations to oral SCY-078 for vulvovaginal candidiasis

May 2, 2018

Symphogen initiates first-in-human study of Sym-022 in advanced solid tumors or lymphomas

May 2, 2018

MEN-1611 demonstrates promising in vivo activity in various cancer models

May 2, 2018

Shire offers overview of first quarter 2018

May 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...